BR112022004489A2 - Composto ou composição para uso - Google Patents

Composto ou composição para uso

Info

Publication number
BR112022004489A2
BR112022004489A2 BR112022004489A BR112022004489A BR112022004489A2 BR 112022004489 A2 BR112022004489 A2 BR 112022004489A2 BR 112022004489 A BR112022004489 A BR 112022004489A BR 112022004489 A BR112022004489 A BR 112022004489A BR 112022004489 A2 BR112022004489 A2 BR 112022004489A2
Authority
BR
Brazil
Prior art keywords
compound
composition
compounds
fatty liver
alcoholic
Prior art date
Application number
BR112022004489A
Other languages
English (en)
Inventor
Jérémie Gautheron
Vlad Ratziu
Original Assignee
Hopitaux Paris Assist Publique
Inst Nat Sante Rech Med
Univ Sorbonne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hopitaux Paris Assist Publique, Inst Nat Sante Rech Med, Univ Sorbonne filed Critical Hopitaux Paris Assist Publique
Publication of BR112022004489A2 publication Critical patent/BR112022004489A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

composto ou composição para uso. a presente invenção se refere a compostos e composições compreendendo os ditos compostos, para uso na prevenção e/ou no tratamento de doença hepática gordurosa não alcoólica (nafld), em particular, esteatose hepática ou esteato-hepatite não alcoólica (nash).
BR112022004489A 2019-10-24 2020-10-23 Composto ou composição para uso BR112022004489A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19306380.7A EP3811937A1 (en) 2019-10-24 2019-10-24 Compounds for use in the prevention and/or treatment of non-alcoholic fatty liver disease
PCT/EP2020/079932 WO2021078958A1 (en) 2019-10-24 2020-10-23 Compounds for use (in particular ripa-56) in the prevention and/or treatment of non-alcoholic fatty liver disease

Publications (1)

Publication Number Publication Date
BR112022004489A2 true BR112022004489A2 (pt) 2022-05-31

Family

ID=68581693

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022004489A BR112022004489A2 (pt) 2019-10-24 2020-10-23 Composto ou composição para uso

Country Status (7)

Country Link
US (1) US20220362179A1 (pt)
EP (2) EP3811937A1 (pt)
JP (1) JP2022554054A (pt)
CN (1) CN114423418A (pt)
BR (1) BR112022004489A2 (pt)
CA (1) CA3151020A1 (pt)
WO (1) WO2021078958A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015371822B2 (en) * 2014-12-24 2020-04-09 National Institute Of Biological Sciences, Beijing Necrosis inhibitors
US10588880B2 (en) * 2016-09-28 2020-03-17 Eiger Biopharmaceuticals, Inc. Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis
EP3612223A4 (en) * 2017-04-17 2020-04-22 National Institute Of Biological Sciences, Beijing TREATMENT OF MALE SENESCENCE

Also Published As

Publication number Publication date
EP4048248A1 (en) 2022-08-31
JP2022554054A (ja) 2022-12-28
CA3151020A1 (en) 2021-04-29
CN114423418A (zh) 2022-04-29
WO2021078958A1 (en) 2021-04-29
US20220362179A1 (en) 2022-11-17
EP3811937A1 (en) 2021-04-28

Similar Documents

Publication Publication Date Title
BR112017016766A2 (pt) composições farmacêuticas para terapia de combinação
CU20210042A7 (es) Compuestos agonistas de glp-1r y composiciones farmacéuticas que lo contienen
BR112021020335A2 (pt) Agonistas glp-1r e usos dos mesmos
BR112014006220A2 (pt) composições de galacto-ramnogalacturonato para o tratamento de esteatohepatite não alcoólica e de doença de gordura no fígado não alcoólica
EA201691590A1 (ru) Бензимидазол-2-амины в качестве ингибиторов midhi
CL2008003582A1 (es) Uso de una composicion farmaceutica que contiene cisteamina o cistamina en la preparacion de un medicamento util para el tratamiento de una enfermedad de higado graso no alcholico (nafld) o esteatohepatitis no alcoholica (nash).
BR112017012327A2 (pt) benzamidas substituídas por 1,3-tiazol-2-il.
CL2013002185A1 (es) Compuestos derivados de terpenos modificados en c-17 y c3, inhibidores de la maduración del vih; compuestos intermediarios; composición farmacéutica que los comprende; su uso para tratar la infección por vih.
BR112015026830A2 (pt) composto, composição farmacêutica, uso de um composto, método para profilaxia ou tratamento de um estado de doença ou condição
PH12015501795A1 (en) A novel composition for nonalcoholic fatty liver disease (nafld)
BR112015018270A2 (pt) composições que compreendem 15-ohepa e métodos de uso das mesmas
AR105493A1 (es) Inhibidor de la isocitrato deshidrogenasa mutada idh1 r132h
BR112018073524A2 (pt) composto, composição farmacêutica, combinação, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método de tratamento de uma doença ou condição.
BR112018010394A2 (pt) anticorpo, conjugado anticorpo-fármaco, composição farmacêutica, e, combinação do anticorpo.
MX2023013577A (es) Composiciones de bismuto-tiol y metodos de uso.
BR112022002496A2 (pt) Compostos deuterados para uso no tratamento de câncer
EA201891651A2 (ru) Фармацевтическая композиция для профилактики алиментарного ожирения
EP3781158A4 (en) COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC FAT LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS
BR112022004489A2 (pt) Composto ou composição para uso
EP3510014A4 (en) COMPOSITIONS AND METHODS FOR USE OF GAMMA KETOALDEHYD CATCHERS FOR TREATING, PREVENTING OR IMPROVING NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), NASH, ALD, OR DISEASES
BR112019006292A2 (pt) composições e métodos
BR112019002213A2 (pt) composições e o uso das mesmas para tratar ou prevenir rosácea
BR112019022918A2 (pt) Agentes farmacêuticos, composições e métodos relativos aos mesmos
BR112018071088A2 (pt) composições inovadoras
BR112022002094A2 (pt) Composição imunogênica